Statistics
Publications
3
Citations
1.1K
H-Index
3
Active since
2002
Affiliations
Jeffrey Allebach is an author at Johns Hopkins Medicine specializing in cancer pharmacology, medicine, and oncology.
Publications per year
2002–2004
3
3
A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo
Mark J. Levis, Jeffrey Allebach, Kam-Fai Tse et al. · Blood · 2002 · 474 citations
Medicine, Oncology, Pharmacology +11
FLT3/ITD Mutation Signaling Includes Suppression of SHP-1
Peili Chen, Mark J. Levis, Patrick A. Brown et al. · Journal of Biological Chemistry · 2004 · 42 citations · Full text
1–3 of 3